Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development

Expert Review of Vaccines

Volumn 8, Issue 2, 2009, Pages 205-213

  Dorella, Fernanda A ^a,b   Pacheco, Luis G C ^b   Seyffert, Núbia ^b   Portela, Ricardo W ^b   Meyer, Roberto ^b   Miyoshi, Anderson ^b   Azevedo, Vasco ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Caseous lymphadenitis; Cheesy gland; Corynebacterium pseudotuberculosis; Diagnostic; Goat; Immunodominant antigen; Immunology; Phospholipase d; Sheep; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; CORYNEBACTERIUM PSEUDOTUBERCULOSIS VACCINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA VACCINE; GLANVAC; PHOSPHOLIPASE D; UNCLASSIFIED DRUG; VACCINE;

ANTIGEN EXPRESSION; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; CASEOUS LYMPHADENITIS; CORYNEBACTERIUM INFECTION; CORYNEBACTERIUM PSEUDOTUBERCULOSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; HOST; IMMUNE RESPONSE; LYMPHADENITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; ANTIGENS, BACTERIAL; CORYNEBACTERIUM INFECTIONS; CORYNEBACTERIUM PSEUDOTUBERCULOSIS; GOAT DISEASES; GOATS; LYMPHADENITIS; SHEEP; SHEEP DISEASES;

EID: 60149093382     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.8.2.205     Document Type: Review

References (87)

1. Dorella FA, Pacheco LGC, Oliveira SC, Miyoshi A, Azevedo V. Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet. Res. 37, 201-218 (2006).
2. Al-Rawashdeh OF, Al-Qudah KM. Effect of shearing on the incidence of caseous lymphadenitis in awassi sheep in Jordan. J. Vet. Med. B 47, 287-293 (2000).
3. Paton MW, Walker SB, Rose IR, Watt GF. Prevalence of caseous lymphadenitis and usage of caseous lymphadenitis vaccines in sheep flocks. Aust. Vet. J. 81, 91-95 (2003).
4. Connor KM, Quirie MM, Baird G, Donachie W. Characterization of United Kingdom isolates of Corynebacterium pseudotuberculosis using pulsed-field gel electrophoresis. J. Clin. Microbiol. 38, 2633-2637 (2000).
5. Ben Said MS, Ben Maitigue H, Benzarti M, Messadi L, Rejeb A, Amara A. Epidemiological and clinical studies of ovine caseous lymphadenitis. Arch. Inst. Pasteur Tunis. 79, 51-57 (2002).
6. Binns SH, Bailey M, Green LE. Postal survey of ovine caseous lymphadenitis in the United Kingdom between 1990 and 1999. Vet. Rec. 150, 263-268 (2002).
7. Arsenault J, Dubreuil P, Girard C, Simard C, Belanger D. Maedi-visna impact on productivity in Quebec sheep flocks (Canada). Prev. Vet. Med. 59, 125-137 (2003).
8. Fontaine MC, Baird GJ. Caseous lymphadenitis. Small Rumin. Res. 76, 42-48 (2008).
9. O'Reilly KM, Green LE, Malone FE, Medley GF. Parameter estimation and simulations of a mathematical model of Corynebacterium pseudotuberculosis transmission in sheep. Prev. Vet. Med. 83, 242-259 (2008).
10. Senturk S, Temizel M. Clinical efficacy of rifamycin SV combined with oxytetracycline in the treatment of caseous lymphadenitis in sheep. Vet. Rec. 159, 216-217 (2006).
11. Ural K, Alic D, Haydardedeoglu AE et al. Corynebacterium pseudotuberculosis infection in SaanenxKilis crossbred (White) goats in Ankara, Turkey and effective kanamycin treatment: a prospective, randomized, double-blinded, placebo-controlled clinical trial. Small Rumin. Res. 77, 84-88 (2008).
12. Baird G. Treatment of ovine caseous lymphadenitis. Vet. Rec. 159, 500 (2006).
13. Menzies PI, Hwang Y-T, Prescott JF. Comparison of an interferon-γ to a phospholipase D enzyme-linked immunosorbent assay for diagnosis of Corynebacterium pseudotuberculosis infection in experimentally infected goats. Vet. Microbiol. 100, 129-137 (2004).
14. Radostits OM, Gay CC, Blood DC, Hinchcliff KW. Clinica Veterindria. Um Tratado de Doenças Dos Bovinos, Ovinos, Suínos, Caprinos e Eqüinos (9th Edition). Koogan G (Ed.). Guanabara, Brazil (2002).
15. Guilloteau L, Pepin M, Pardon P, Le Pape A. Recruitment of 99m-technetium- or 111-indium-labelled polymorphonuclear leucocytes in experimentally induced pyogranulomas in lambs. J. Leukocyte Biol. 48, 343-352 (1990).
16. Hard GC. Electron microscopic study of the differentiation of mouse peritoneal macrophages stimulated by Corynebacterium ovis infection. Lab. Invest. 21, 309-315 (1969).
17. Tashjian JJ, Campbell SG. Interaction between caprine macrophages and Corynebacterium pseudotuberculosis: an electron microscopy study. Am. J. Vet. Res. 44, 690-693 (1983).
18. Pépin M, Pardon P, Marly J, Lantier F. Corynebacterium pseudotuberculosis infection in adult ewes by inoculation in the external ear. Am. J. Vet. Res. 49, 459-463 (1988).
19. Pépin M, Fontaine JJ, Pardon P, Marly J, Parodi AL. Histopathology of the early phase during experimental Corynebacterium pseudotuberculosis infection in lambs. Vet. Microbiol. 29, 123-134 (1991).
20. McKean S, Davies J, Moore R. Identification of macrophage induced genes of Corynebacterium pseudotuberculosis by differential fluorescence induction. Microb. Infect. 7, 1352-1363 (2005).
21. Hard GC. Comparative toxic effect of the surface lipid of Corynebacterium ovis on peritoneal macrophages. Infect. Immun. 12, 1439-1449 (1975).
22. Baird GJ, Fontaine MC. Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis. J. Comp. Pathol. 137, 179-210 (2007).
23. Songer JG. Bacterial phospholipases and their role in virulence. Trends Microbiol. 5, 156-161 (1997).
24. Cameron CM. The immunogenicity of Corynebacterium pseudotuberculosis. Proc. Goat Prod. Dis. 3, 458-468 (1982).
25. Brown CC, Olander HJ, Biberstein EL, Morse SM. Use of a toxoid vaccine to protect goats against intradermal challenge exposure to Corynebacterium pseudotuberculosis. Am. J. Vet. Res. 47, 1116-1119 (1986).
26. Pépin M, Seow HF, Corner L, Rothel JS, Hodgson AL, Wood PR. Cytokine gene expression in sheep following experimental infection with various strains of Corynebacterium pseudotuberculosis differing in virulence. Vet. Res. 28, 149-163 (1997).
27. Jolly RD. The pathogenesis of experimental Corynebacterium ovis infection in mice. NZ Vet. J. 13, 141-147 (1965).
28. Pepin M, Pittet J-C, Olivier M, Gohint I. Cellular composition of Corynebacterium pseudotuberculosis pyogranulomas in sheep. J. Leukocyte Biol. 56, 666-670 (1994).
29. Kuria JKN, Mbuthia PG, Kang'ethe EK, Wahome RG. Caseous lymphadenitis in goats: the pathogenesis, incubation period and serological response after experimental infection. Vet. Res. Commun. 25, 89-97 (2001).
30. Pépin M, Pardon P, Lantier F, Marly J, Levieux D, Lamand M. Experimental Corynebacterium pseudotuberculosis infection in lambs: kinetics of bacterial dissemination and inflammation. Vet. Microbiol. 26, 381-392 (1991).
31. Walker J, Jackson H, Brandon MR, Meeusen E. Lymphocyte subpopulations in pyogranulomas of caseous lymphadenitis. Clin. Exp. Immunol. 86, 13-18 (1991).
32. Modlin RL, Melancon-Kaplan J, Young SMM et al. Learning from lesions: patterns of tissue inflammation in leprosy. Proc. Natl Acad. Sci. USA 85, 1213-1217 (1988).
33. Garg DN, Chandiramani NK. Cellular and humoral immune response in sheep experimentally injected with killed and live Corynebacterium pseudotuberculosis. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 260, 117-125 (1985).
34. El-Enbaawy MI, Saad MM, Selim SA. Humoral and cellular immune responses of a murine model against Corynebacterium pseudotuberculosis antigens. Egypt. J. Immunol. 12, 13-20 (2005).
35. Ellis JA, Hawk DA, Mills KW, Pratt DL. Antigen specificity and activity of ovine antibodies induced by immunization with Corynebacterium pseudotuberculosis culture filtrate. Vet. Immunol. Immunopathol. 28, 303-316 (1991).
36. Paule BJA, Azevedo V, Regis LF et al. Experimental Corynebacterium pseudotuberculosis primary infection in goats: kinetics of IgG and interferon-γ production, IgG avidity and antigen recognition by western blotting. Vet. Immunol. Immunopathol. 96, 129-139 (2003).
37. Meyer R, Regis L, Vale V et al. In vitro IFN-γ production by goat blood cells after stimulation with somatic and secreted Corynebacterium pseudotuberculosis antigens. Vet. Immunol. Immunopathol. 107, 249-254 (2005).
38. Sunil V, Menzies PI, Shewen PE, Prescott JF. Performance of a whole blood interferon-y assay for detection and eradication of caseous lymphadenitis in sheep. Vet. Microbiol. 128, 288-297 (2008).
39. Simmons CP, Hodgson AL, Strugnell RA. Attenuation and vaccine potential of aro Q mutants of Corynebacterium pseudotuberculosis. Infect. Immun. 65, 3048-3056 (1997).
40. Lan DT, Taniguchi S, Makino S, Shirahata T, Nakane A. Role of endogenous tumor necrosis factor a and γ interferon in resistance to Corynebacterium pseudotuberculosis infection in mice. Microbiol. Immunol. 42, 863-870 (1998).
41. Lan DT, Makino S, Shirahata T, Yamada M, Nakane A. Tumor necrosis factor α and γ interferon are required for the development of protective immunity to secondary Corynebacterium pseudotuberculosis infection in mice. J. Vet. Med. Sci. 61, 1203-1208 (1999).
42. Eckersall PD, Lawson FP, Bence L et al. Acute phase protein response in an experimental model of ovine caseous lymphadenitis. BMC Vet. Res. 3, 35-40 (2007).
43. + cell-depleted mice. Infect. Immun. 59, 3439-3445 (1991).
44. Denis M. Modulation of Mycobacterium lepraemurium: growth in murine macrophages: beneficial effect of tumor necrosis factor a and granulocyte-macrophage colony stimulating factor. Infect. Immun. 59, 705-707 (1991).
45. Braithwaite CE, Smith EE, Songer JG, Reine AH. Characterization of detergent soluble proteins of Corynebacterium pseudotuberculosis. Vet. Microbiol. 38, 59-70 (1993).
46. Paule B, Azevedo V, Moura-Costa LF et al. SDS-PAGE and western blot analysis of somatic and extracellular antigens of Corynebacterium pseudotuberculosis. R. Ci. Méd. Biol. 3, 44-52 (2004).
47. McKean SC, Davies JK, Moore RJ. Probing the heat shock response of Corynebacterium pseudotuberculosis: the major virulence factor, phospholipase D, is downregulated at 43°C. Res. Microbiol. 158, 279-286 (2007).
48. Muckle CA, Menzies PI, Li Y, Hwang Y-T, van Wesenbeeck M. Analysis of the immunodominant antigens of Corynebacterium pseudotuberculosis. Vet. Microbiol. 30, 47-58 (1992).
49. Williamson LH. Caseous lymphadenitis in small ruminants. Vet. Clin. North Am. Food Anim. Pract. 17, 359-371 (2001).
50. Fontaine MC, Baird G, Connor KM et al. Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis. Vaccine 24, 5986-5996 (2006).
51. Menzies PI, Muckle CA, Hwang YT, Songer JG. Evaluation of an enzyme-linked immunosorbent assay using an Escherichia coli recombinant phospholipase D antigen for the diagnosis of Corynebacterium pseudotuberculosis infection. Small Rumin. Res. 13, 193-198 (1994).
52. Hodgson ALM, Carter K, Tachedjian M et al. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D. Vaccine 17, 802-808 (1999).
53. Brogden KA, Chedid L, Cutlip RC, Lehmkuhl HD, Sacks J. Effect of MDP on immunogenicity of Corynebacterium pseudotuberculosis whole-cell vaccines in mice and lambs. Am. J. Vet. Res. 51, 200-202 (1990).
54. Walker J, Jackson HJ, Eggleton DG, Meeusen ENT, Wilson MJ, Brandon MR. Identification of a novel antigen from Corynebacterium pseudotuberculosis that protects sheep against caseous lymphadenitis. Infect. Immun. 62, 2562-2567, (1994).
55. Prescott JF, Menzies PI, Hwang Y-T. An interferon-y assay for diagnosis of Corynebacterium pseudotuberculosis infection in adult sheep from a research flock. Vet. Microbiol. 88, 287-297 (2002).
56. Binns SH, Green LE, Bailey M. Development and validation of an ELISA to detect antibodies to Corynebacterium pseudotuberculosis in ovine sera. Vet. Microbiol. 123, 169-179 (2007).
57. Dercksen DP, Brinkhof JMA, Dekker-Noorenb T et al. A comparison of four serological tests for the diagnosis of caseous lymphadenitis in sheep and goats. Vet. Microbiol. 75, 167-175 (2000).
58. Carminatti R, Bahia R, Moura-Costa LF et al. Determinaç ão da sensibilidade e da especificidade de um teste de ELISA indireto para o diagnóstic) de linfadenite caseosa em caprinos. R. Ci. Med. Biol. 2, 88-93 (2003).
59. ter Laak EA, Bosch J, Bijl GC, Schreuder BE. Double-antibody sandwich enzyme linked immunosorbent assay and immunoblot analysis used for control of caseous lymphadenitis in goats and sheep. Am. J. Vet. Res. 53, 1125-1132 (1992).
60. Day MJ. Vaccine side effects: fact and fiction. Vet. Microbiol. 117, 51-58 (2006).
61. Stanford K, Brogden KA, McClelland LA, Kozub GC, Audibert F. The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines. Can. J. Vet. Res. 62, 38-43 (1998).
62. Eggleton DG, Middleton HD, Doidge CV, Minty DW. Immunisation against ovine caseous lymphadenitis: comparison of Corynebacterium pseudotuberculosis vaccines with and without bacterial cells. Aust. Vet. J. 68, 317-319 (1991).
63. Piontkowski MD, Shivvers DW. Evaluation of a commercially available vaccine against Corynebacterium pseudotuberculosis for use in sheep. J. Am. Vet. Med. Assoc. 212, 1765-1768 (1998).
64. Paton MW, Sutherland SS, Rose IR, Hart RA, Mercy AR, Ellis TM. The spread of Corynebacterium pseudotuberculosis infection to unvaccinated and vaccinated sheep. Aust. Vet. J. 7, 266-269 (1995).
65. Ribeiro OC, Silva JAH, Oliveira SC, Meyer R, Fernandes GB. Dados preliminares sobre uma vacina viva contra a linfadenite caseosa. Pesq. Agropec. Bras. 26, 461-465 (1991).
66. Hodgson ALM, Tachedjian M, Corner LA, Radford AJ. Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis. Infect. Immun. 62, 5275-5280 (1994).
67. Simmons CP, Dunstan SJ, Tachedjian M, Krywult J, Hodgson ALM, Strugnell RA. Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep. Infect. Immun. 66, 474-479 (1998).
68. Braga WU. Protection in alpacas against Corynebacterium pseudotuberculosis using different bacterial components. Vet. Microbiol. 119, 297-303 (2007).
69. Tachedjian M, Krywult J, Moore RJ, Hodgson ALM. Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D gene. Vaccine 13, 1785-1792 (1995).
70. Moore RJ, Rothel L, Krywult J, Radford AJ, Lund KL, Hodgson ALM. Foreign gene expression in Corynebacterium pseudotuberculosis: development of a live vaccine vector. Vaccine 18, 487-497 (2000).
71. Chaplin PJ, de Rose R, Boyle JS et al. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect. Immun. 67, 6434-6438 (1999).
72. De Rose R, Tennent J, McWaters P et al. Efficacy of DNA vaccination by different routes of immunisation in sheep. Vet. Immunol. Immunopathol. 90, 55-63 (2002).
73. Wilson MJ, Brandon MR, Walker J. Molecular and biochemical characterization of a protective 40-kilodalton antigen from Corynebacterium pseudotuberculosis. Infect. Immun. 63, 206-211 (1995).
74. Pepin M, Pardon P, Marly J, Lantier F, Arrigo JL. Acquired immunity after primary caseous lymphadenitis in sheep. Am. J. Vet. Res. 54, 873-877 (1993).
75. Hodgson AL, Krywult J, Corner LA, Rothel JS, Radford AJ. Rational attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle. Infect. Immun. 60, 2900-2905 (1992).
76. Moore RJ, Stewart DJ, Lund K, Hodgson AL. Vaccination against ovine footrot using a live bacterial vector to deliver basic protease antigen. FEMS Microbiol. Lett. 194, 193-196 (2001).
77. Moura-Costa LF, Bahia RC, Carminati R et al. Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis. Vet. Immunol. Immunopathol. 126, 131-141 (2008).
78. Paule BJA, Meyer R, Moura-Costa LF et al. Three-phase partitioning as an efficient method for extraction/concentration of immunoreactive excreted-secreted proteins of Corynebacterium pseudotuberculosis. Protein Expr. Purif. 34, 311-316 (2004).
79. Babiuk LA. Broadening the approaches to developing more effective vaccines. Vaccine 17, 1587-1595 (1999).
80. Ellis RW. Technologies for the design, discovery, formulation and administration of vaccines. Vaccine 19, 2681-2687 (2001).
81. Pacheco LG, Pena RR, Castro TL et al. Multiplex PCR assay for identification of Corynebacterium pseudotuberculosis from pure cultures and for rapid detection of this pathogen in clinical samples. J. Med. Microbiol. 56, 480-486 (2007).
82. Ellis JA, Hawk DA, Mills KW, Pratt DL. Antigen specificity of antibody responses to Corynebacterium pseudotuberculosis in naturally infected sheep with caseous lymphadenitis. Vet. Immunol. Immunopathol. 28, 289-301 (1991).
83. Nigou J, Gilleron M, Puzo G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 85, 153-166 (2003).
84. Delbridge LM, O'Riordan MXD. Innate recognition of intracellular bacteria Curr. Opin. Immunol. 19, 10-16 (2007).
85. Jo EK. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr. Opin. Infect. Dis. 21, 279-286 (2008).
86. Majlessi L, Combaluzier B, Albrecht I et al. Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules. J. Immunol. 179, 1825-1833 (2007).
87. Billington SJ, Esmay PA, Songer JG, Jost BH. Identification and role in virulence of putative iron acquisition genes from Corynebacterium pseudotuberculosis. FEMS Microbiol. Lett. 208, 41-45 (20002)